Invention Grant
US08748395B2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
有权
细胞渗透性肽抑制剂的JNK信号转导途径
- Patent Title: Cell-permeable peptide inhibitors of the JNK signal transduction pathway
- Patent Title (中): 细胞渗透性肽抑制剂的JNK信号转导途径
-
Application No.: US12066657Application Date: 2006-09-12
-
Publication No.: US08748395B2Publication Date: 2014-06-10
- Inventor: Christophe Bonny
- Applicant: Christophe Bonny
- Applicant Address: CY Limassol
- Assignee: Xigen Inflammation Ltd.
- Current Assignee: Xigen Inflammation Ltd.
- Current Assignee Address: CY Limassol
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/EP2006/008882 WO 20060912
- International Announcement: WO2007/031280 WO 20070322
- Main IPC: A61K38/08
- IPC: A61K38/08 ; A61K38/10 ; A61K38/16 ; C07K14/00 ; C07K7/08 ; C07K7/06 ; C07K16/00 ; C12P21/06
Abstract:
Protein kinase inhibitors and more specifically inhibitors of the protein kinase c-Jun amino terminal kinase are described. Additionally, JNK inhibitor sequences, chimeric peptides, nucleic acids encoding same as well as pharmaceutical compositions for treating pathophysiologies associated with JNK signaling are described.
Public/Granted literature
- US20090305968A1 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway Public/Granted day:2009-12-10
Information query
IPC分类:
